SCHOTT Pharma USA, Inc.
SCHOTT Pharma is a global leader in pharmaceutical and biotech solutions, providing advanced drug containment and delivery systems for over 100 years. Their portfolio includes prefillable syringes, cartridges, vials, and ampoules, along with analytical, development, fill-and-finish, and regulatory services. Committed to science-driven innovation, quality, and human health, SCHOTT Pharma supports the entire pharmaceutical value chain from raw materials to patient delivery, emphasizing safety, reliability, and sustainability.
Industries
Nr. of Employees
Very Large (1000+)
SCHOTT Pharma USA, Inc.
Hattenbergstraße 10, 55122 Mainz, Germany
Products
Prefillable syringes (glass)
Glass prefillable syringes manufactured from borosilicate glass with dimensional control and options to minimize silicone or particulate-related interactions to support biologic stability and consistent injection performance.
Prefillable syringes (polymer, COC)
Polymer prefillable syringes made from cyclic olefin copolymer with coatings and material controls to reduce contamination risk and improve stability for sensitive biologics and cold-chain products.
Cartridges (single- and double-chamber, RTU)
High-precision cartridges in single- and large-volume formats with double-chamber options for lyophilized drugs and ready-to-use delivery formats for pen injectors, autoinjectors and wearable devices.
Ultra-pure vials with surface treatment
Ultra-pure pharmaceutical vials with surface-treatment options to reduce adsorption and delamination risk, intended to improve stability of biologic formulations and compatibility with modern fill-and-finish lines.
Ampoules
Borosilicate glass ampoules manufactured with tight dimensional and cosmetic control for sterile single-dose storage and administration.
Sterile barrier bags and RTU secondary packaging components
Sterile protective bags and secondary packaging components designed to protect RTU containers, provide robust sealing and support visual inspection workflows.
Prefillable syringes (glass)
Glass prefillable syringes manufactured from borosilicate glass with dimensional control and options to minimize silicone or particulate-related interactions to support biologic stability and consistent injection performance.
Prefillable syringes (polymer, COC)
Polymer prefillable syringes made from cyclic olefin copolymer with coatings and material controls to reduce contamination risk and improve stability for sensitive biologics and cold-chain products.
Cartridges (single- and double-chamber, RTU)
High-precision cartridges in single- and large-volume formats with double-chamber options for lyophilized drugs and ready-to-use delivery formats for pen injectors, autoinjectors and wearable devices.
Ultra-pure vials with surface treatment
Ultra-pure pharmaceutical vials with surface-treatment options to reduce adsorption and delamination risk, intended to improve stability of biologic formulations and compatibility with modern fill-and-finish lines.
Ampoules
Borosilicate glass ampoules manufactured with tight dimensional and cosmetic control for sterile single-dose storage and administration.
Sterile barrier bags and RTU secondary packaging components
Sterile protective bags and secondary packaging components designed to protect RTU containers, provide robust sealing and support visual inspection workflows.
Services
Accredited laboratory testing for material compatibility, stability, extractables and leachables, and container closure integrity to support clinical development and regulatory submissions.
Flexible sterile filling operations for syringes, cartridges and vials from early-sample volumes to scalable clinical and commercial production, with supply of ready-to-use sterile packaging to protect aseptic integrity.
Process analysis and optimization services to identify weak spots, reduce glass damage and improve handling across fill-and-finish lines and automated handling systems.
Concept evaluation, prototyping, feasibility testing and documentation (design history files) for primary packaging and drug delivery containment solutions.
Consulting and documentation services to generate packaging-related evidence, prepare clinical trial applications and support marketing authorization dossiers.
Development and implementation of circular packaging concepts and ecodesign assessments, including closed-loop recycling programs for transport and secondary packaging.
Accredited laboratory testing for material compatibility, stability, extractables and leachables, and container closure integrity to support clinical development and regulatory submissions.
Flexible sterile filling operations for syringes, cartridges and vials from early-sample volumes to scalable clinical and commercial production, with supply of ready-to-use sterile packaging to protect aseptic integrity.
Process analysis and optimization services to identify weak spots, reduce glass damage and improve handling across fill-and-finish lines and automated handling systems.
Concept evaluation, prototyping, feasibility testing and documentation (design history files) for primary packaging and drug delivery containment solutions.
Consulting and documentation services to generate packaging-related evidence, prepare clinical trial applications and support marketing authorization dossiers.
Development and implementation of circular packaging concepts and ecodesign assessments, including closed-loop recycling programs for transport and secondary packaging.
Expertise Areas
- Primary packaging design for injectable drugs
- GMP manufacturing and aseptic fill-and-finish
- Analytical testing for container compatibility, extractables/leachables and stability
- Regulatory support for packaging-related submissions
Key Technologies
- Borosilicate glass primary containers
- Cyclic olefin copolymer (COC) polymer containers
- Prefillable syringe formats
- Single- and double-chamber cartridge formats
News & Updates
SCHOTT Pharma collaborates with SHL Medical to improve home-based large-volume injection solutions.
The Supervisory Board of SCHOTT Pharma has extended the contract of CEO Andreas Reisse and appointed Reinhard Mayer as the new CFO.
The company announces a new investment in sterile cartridge manufacturing facilities in Hungary.
Explores the pathway to develop net-zero emission injection devices through cross-industry collaboration.
Details how closed loop recycling of pharma packaging trays can reduce plastic demand and carbon emissions.
Discusses integrating ecodesign in pharmaceutical product development to ensure safety and environmental sustainability.
SCHOTT Pharma collaborates with SHL Medical to improve home-based large-volume injection solutions.
The Supervisory Board of SCHOTT Pharma has extended the contract of CEO Andreas Reisse and appointed Reinhard Mayer as the new CFO.
The company announces a new investment in sterile cartridge manufacturing facilities in Hungary.
Explores the pathway to develop net-zero emission injection devices through cross-industry collaboration.
Details how closed loop recycling of pharma packaging trays can reduce plastic demand and carbon emissions.
Discusses integrating ecodesign in pharmaceutical product development to ensure safety and environmental sustainability.